Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
152.95B
Market cap152.95B
Price-Earnings ratio
14.56
Price-Earnings ratio14.56
Dividend yield
6.25%
Dividend yield6.25%
Average volume
73.17M
Average volume73.17M
High today
$27.36
High today$27.36
Low today
$26.80
Low today$26.80
Open price
$27.26
Open price$27.26
Volume
29.75M
Volume29.75M
52 Week high
$30.43
52 Week high$30.43
52 Week low
$20.92
52 Week low$20.92

PFE News

Sherwood News 3h
Can pharma companies put tariff threats behind them?

Big Pharma may have gotten Trump off its back for now. But are drug prices coming down? For the past nine months, pharmaceutical companies have been paralyzed...

Can pharma companies put tariff threats behind them?
Nasdaq 6h
Great News for Pfizer Stock Investors

Pfizer (NYSE: PFE) made a deal with the White House to avoid paying tariffs on imported products. Where to invest $1,000 right now? Our analyst team just revea...

Great News for Pfizer Stock Investors
TipRanks 7h
Pfizer’s Mixed Financial Outlook: Hold Rating Amid Growth Potential and Challenges

Pfizer, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Chris Schott from J.P. Morgan maintained a Hold rating on the stock...

Analyst ratings

60%

of 25 ratings
Buy
36%
Hold
60%
Sell
4%

More PFE News

24/7 Wall St. 13h
Energy Transfer, Pfizer, and Realty Income Offer 5%+ Yields With Strong Payout Coverage

Home Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years...

Energy Transfer, Pfizer, and Realty Income Offer 5%+ Yields With Strong Payout Coverage
The Motley Fool 1d
Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.

These stocks can make your money work for you. I've become increasingly fonder of dividend stocks the older I've gotten. Part of the attraction is that I would...

Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.
Simply Wall St 2d
Pfizer Is Up 15.2% After Historic US Drug Price Deal and Tariff Exemption

In the past week, Pfizer reached a landmark agreement with the U.S. government to lower prices across a wide selection of prescription drugs, including aligning...

Pfizer Is Up 15.2% After Historic US Drug Price Deal and Tariff Exemption
TipRanks 3d
Trump Weekly: White House announces drug pricing deal with Pfizer

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump with th...

TipRanks 3d
Analyst Sees ‘Attractive Entry Point’ for Johnson & Johnson Stock after Trump-Pfizer Deal

The shares of pharmaceutical giant Johnson & Johnson (JNJ) rose on Friday afternoon after the stock earned new price boosts from U.S. banking titans Wells Fargo...

The Motley Fool 3d
Why Shares of Eli Lilly Soared This Week

Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs. Shares in Eli Lilly (LLY 2.73%) had risen 13.2...

Why Shares of Eli Lilly Soared This Week
TipRanks 3d
Pfizer price target raised to $30 from $28 at BofA

BofA analyst Tim Anderson raised the firm’s price target on Pfizer (PFE) to $30 from $28 and keeps a Neutral rating on the shares. While the timing of President...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.